• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[禁食饮食疗法对慢性肝胆系统损伤患者激肽释放酶-激肽系统的影响评估]

[Evaluation of the kallikrein-kinin system in patients with chronic impairments of the hepatobiliary system as affected by fasting-diet therapy].

作者信息

Krys'kiv O I

机构信息

I.Ya. Gorbachevsky Ternopil Medical Academy.

出版信息

Ukr Biokhim Zh (1978). 1997 May-Jun;69(3):104-8.

PMID:9505369
Abstract

Evaluation of kallikrein-kinin circulatory system was performed via kallikrein, prekallikrein, a1-inhibitor proteinase, a2-macroglobulin, kininase-II and proteolytic activity in 60 patients with chronic persisting hepatitis and incalculous cholecystitis. Two types of kallikrein-kinin system reaction were revealed: hyperkininogenesis in 85% and hypokininogenesis in 15% of all the patients. The problem of fasting diabetics influence on kininogenesis was investigated as well.

摘要

通过检测60例慢性持续性肝炎和非结石性胆囊炎患者的激肽释放酶、前激肽释放酶、α1-抑制蛋白酶、α2-巨球蛋白、激肽酶II和蛋白水解活性,对激肽释放酶-激肽循环系统进行了评估。结果发现激肽释放酶-激肽系统反应有两种类型:所有患者中85%为激肽生成亢进,15%为激肽生成减退。同时还研究了空腹糖尿病患者对激肽生成的影响问题。

相似文献

1
[Evaluation of the kallikrein-kinin system in patients with chronic impairments of the hepatobiliary system as affected by fasting-diet therapy].[禁食饮食疗法对慢性肝胆系统损伤患者激肽释放酶-激肽系统的影响评估]
Ukr Biokhim Zh (1978). 1997 May-Jun;69(3):104-8.
2
[State of the kallikrein-kinin system in patients with chronic inflammatory diseases of the liver].[肝脏慢性炎症性疾病患者激肽释放酶-激肽系统的状态]
Ross Med Zh. 1992(1):9-10.
3
[Status of the kallikrein-kinin system, proteinase inhibitors and nonspecific resistance factors in patients with chronic kidney failure on hemodialysis as well as in kidney transplant recipients].[血液透析慢性肾衰竭患者及肾移植受者中激肽释放酶-激肽系统、蛋白酶抑制剂和非特异性抵抗因子的状态]
Vopr Med Khim. 1991 Sep-Oct;37(5):40-3.
4
[Kallikrein-kinin system in acute empyema of pleura and pyopneumothorax].[胸膜急性脓胸和气胸合并感染中的激肽释放酶-激肽系统]
Khirurgiia (Mosk). 1999(7):40-2.
5
[An experimental model of depletion of the blood kallikrein-kinin system].[血液激肽释放酶-激肽系统耗竭的实验模型]
Biull Eksp Biol Med. 1993 Oct;116(10):343-4.
6
Kallikrein-kinin system in patients with neoplastic diseases.肿瘤疾病患者的激肽释放酶-激肽系统
Rocz Akad Med Bialymst. 1996;41(2):417-28.
7
[The use of the kallikrein-kininogen system indices in the prognosis of the development of hemorrhagic erysipelas].
Lab Delo. 1991(8):44-7.
8
Activation of the kallikrein-kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases.激肽释放酶-激肽系统的激活以及微生物和人类细胞蛋白酶通过对激肽原的选择性切割释放新的激肽。
Biol Chem. 2004 Nov;385(11):989-96. doi: 10.1515/BC.2004.129.
9
[Kallikrein-kinin system: novel facts and concepts (literature review)].[激肽释放酶-激肽系统:新事实与概念(文献综述)]
Vopr Med Khim. 2001 Jan-Feb;47(1):20-42.
10
Kallikrein-kinin system activation and its interactions with other plasma haemostatic components in the coronary artery disease.激肽释放酶-激肽系统激活及其在冠状动脉疾病中与其他血浆止血成分的相互作用。
Rocz Akad Med Bialymst. 2001;46:209-24.